Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study

被引：0
|
作者：
Emma C. Gertsen
Arjen van der Veen
Hylke J. F. Brenkman
Lodewijk A. A. Brosens
Rachel S. van der Post
Rob H. A. Verhoeven
Josianne C. H. B. M. Luijten
Pauline A. J. Vissers
Erik Vegt
Richard van Hillegersberg
Peter D. Siersema
Jelle P. Ruurda
机构：
[1] University Medical Center Utrecht,Division Cancer Center, Department of Surgery
[2] Utrecht University,Department of Pathology
[3] Department of Surgery,Department of Pathology
[4] Meander Medical Center,Department of Research and Development
[5] University Medical Center Utrecht,Department of Medical Oncology
[6] Utrecht University,Department of Radiology and Nuclear Medicine
[7] Radboud University Medical Center,Department of Gastroenterology and Hepatology
[8] Netherlands Comprehensive Cancer Organization (IKNL),undefined
[9] Amsterdam UMC,undefined
[10] Erasmus MC University Medical Center Rotterdam,undefined
[11] Radboud University Medical Center,undefined
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
Gastric cancer; Diffuse type; Signet ring cell carcinoma; Perioperative treatment; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1760 / 1772
页数：12
相关论文
共 50 条
  • [31] Primary Signet-ring Cell Carcinoma of the Urinary Bladder A Clinicopothologic and Immunohistochemical Study of 5 Cases
    Del Sordo, Rachele
    Bellezza, Guido
    Colella, Renato
    Mameli, Maria Grazia
    Sidoni, Angelo
    Cavaliere, Antonio
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (01) : 18 - 22
  • [32] Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis
    Tang, Chao-Tao
    Chen, Youxiang
    Zeng, Chunyan
    AGING-US, 2020, 12 (21): : 22059 - 22077
  • [33] Endoscopic and clinicopathologic features of early gastric signet ring cell carcinoma ≤20 mm: a retrospective observational study
    Xu, Jianing
    Zhu, Jingyi
    Lin, Lanhui
    Li, Zhiyu
    Gu, Feng
    Wang, Fangning
    Zhai, Huihong
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (01) : 38 - 44
  • [34] Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study
    Zhang, Shuairan
    Liu, Yang
    Jiao, Zihan
    Li, Zenan
    Wang, Jin
    Li, Ce
    Qu, Xiujuan
    Xu, Ling
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature
    Keita Kai
    Masaaki Satake
    Osamu Tokunaga
    World Journal of Gastroenterology, 2018, (26) : 2915 - 2920
  • [36] Prediction of lymph node metastasis in early gastric signet-ring cell carcinoma: A real-world retrospective cohort study
    Yang, Jia-Jia
    Wang, Xiao-Yong
    Ma, Rui
    Chen, Mei-Hong
    Zhang, Guo-Xin
    Li, Xuan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (24) : 3807 - 3824
  • [37] Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
    Alradhi, Mohammed
    Safi, Mohammed
    Tao, Shenghua
    Al-danakh, Abdullah
    Almoiliqy, Marwan
    Baldi, Salem
    Li, Xiancheng
    THERAPEUTIC ADVANCES IN UROLOGY, 2022, 14
  • [38] Rectal Versus Non-rectal Primary Signet Ring Cell Carcinoma of the Colorectum: a Retrospective Survival Analysis Controlled for Confounders
    Ciarrocchi A.
    Journal of Gastrointestinal Cancer, 2014, 45 (3) : 312 - 318
  • [39] Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study
    Yang, Yu
    Li, Yuxuan
    Du, Xiaohui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database
    Nie, Duorui
    Zheng, Hao
    An, Guilin
    Li, Jing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8593 - 8603
12345